Evaluate the safety and tolerability of lacosamide when given as iv infusions in subjects who are receiving oral lacosamide in addition to up to 3 concomitant AEDs for partial seizures. The primary variables are adverse events
Seizure counts, trough and measured maximum concentration for lacosamide as well as the O-desmethyl-metabolite.
16 Years and older (Child, Adult, Senior)
September 9, 2005
September 22, 2014
Schwarz RTP, North Carolina, United States
† Study has passed its completion date and status has not been verified in more than two years.